India Generic Injectables Market 2022: Size, Share, Trends, Outlook and Future Scope 2027
According to the latest report by IMARC Group, titled “India Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The India generic injectables market reached a value of US$ 2.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2027, exhibiting a CAGR of 12.8% during 2022-2027.
Generic injectables refer to pharmaceutical drugs that consist of active ingredients, effectiveness, intended use, strength, quality, and dosage that are similar to their branded counterparts. They can be divided into various kinds, including monoclonal antibodies, insulin, cytokines, peptide hormones, blood factors, vaccines, etc. Generic injectables are utilized to treat several life-threatening and chronic diseases, such as cancer, diabetes, cardiovascular ailments, rheumatoid arthritis, and respiratory infections. Compared to innovator drugs, they aid in ensuring maximized patient compliance, limited price erosion, reduced frequency of drug delivery, higher profitability for manufacturers, etc. As a result, generic injectables find widespread applications across hospitals, clinics, medical centers, pharmacies, etc.
Request Free Sample Report: https://www.imarcgroup.com/india-generic-injectables-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Market Trends:
The escalating prevalence of chronic diseases, owing to the rising pollution levels and the unhealthy lifestyles of individuals, is primarily driving the India generic injectables market. Apart from this, the development of advanced drug variants for effective administration and faster recovery of patients is further augmenting the market growth. Moreover, the improving healthcare facilities are also catalyzing the market across India. In addition to this, the expanding life science sector and the inflating technological advancements in drug delivery systems, including the introduction of self-injection devices, are acting as significant growth-inducing factors. Furthermore, the increasing expiry of branded medicines and patent items is expected to bolster the India generic injectables market in the coming years.
India Generic Injectables Market 2022-2027 Analysis and Segmentation:
The report has segmented the market on the basis on region, therapeutic area, container, distribution channel.
Breakup by Therapeutic Area:
Oncology
Anaesthesia
Anti-infectives
Parenteral Nutrition
Cardiovascular
Breakup by Container:
Vials
Ampoules
Premix
Prefilled Syringes
Breakup by Distribution Channel:
Hospitals
Retail Pharmacy
Breakup by Region:
North India
West and Central India
South India
East India
Ask Analyst for Customization and Explore Full Report with TOC List of Figure: https://www.imarcgroup.com/india-generic-injectables-market
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Related Report by IMARC Group:
Protein Detection & Quantification Market Report: https://www.imarcgroup.com/protein-detection-quantification-market
Aerosol Delivery Devices Market Report: https://www.imarcgroup.com/aerosol-delivery-devices-market
Onychomycosis Treatment Market Report: https://www.imarcgroup.com/onychomycosis-treatment-market
Lateral Flow Assay Market Report: https://www.imarcgroup.com/lateral-flow-assay-market
Tissue Banking Market Report: https://www.imarcgroup.com/tissue-banking-market
Drug Device Combination Products Market Report: https://www.imarcgroup.com/drug-device-combination-products-market
Formulation Development Outsourcing Market Report: https://www.imarcgroup.com/formulation-development-outsourcing-market
Europe DNA Sequencing Products Market Report: https://www.imarcgroup.com/europe-dna-sequencing-products-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800